VC
LLY icon

Vicus Capital’s Eli Lilly LLY Stock Holding History

Vicus Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$475K Buy
516
+47
+10% +$47.6K 0.03% 181
2025
Q4 		$504K Buy
469
+55
+13% +$52.6K 0.04% 182
2025
Q3 		$316K Buy
414
+33
+9% +$24.6K 0.02% 215
2025
Q2 		$297K Sell
381
-132
-26% -$103K 0.02% 215
2025
Q1 		$424K Sell
513
-35
-6% -$29.1K 0.04% 155
2024
Q4 		$423K Buy
548
+104
+23% +$86.1K 0.04% 149
2024
Q3 		$393K Sell
444
-381
-46% -$343K 0.03% 157
2024
Q2 		$747K Sell
825
-36
-4% -$28.8K 0.07% 114
2024
Q1 		$670K Buy
861
+314
+57% +$223K 0.06% 123
2023
Q4 		$319K Sell
547
-430
-44% -$251K 0.03% 162
2023
Q3 		$525K Buy
977
+430
+79% +$222K 0.06% 140
2023
Q2 		$256K Buy
+547
New +$229K 0.03% 184
2023
Q1 		– Sell
-684
Closed -$250K – 211
2022
Q4 		$250K Sell
684
-261
-28% -$92.5K 0.03% 176
2022
Q3 		$305K Buy
945
+155
+20% +$49.1K 0.04% 170
2022
Q2 		$256K Buy
790
+83
+12% +$24.9K 0.03% 186
2022
Q1 		$202K Buy
+707
New +$182K 0.02% 221

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vicus Capital's LLY Position: Q1 2026 in Review

Vicus Capital increased its Eli Lilly (LLY) stake by 10% in Q1 2026, buying an estimated $47.6K and bringing the position to 516 shares worth $475K. The position accounts for 0.03% of the portfolio, ranked #181.

Vicus Capital first reported a position in LLY in Q1 2022 and has held it in 16 quarters since. The position peaked at $747K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vicus Capital held 516 shares of Eli Lilly worth $475K as of Q1 2026.
  • Vicus Capital bought 47 Eli Lilly shares in Q1 2026, an estimated $47.6K.
  • Eli Lilly made up 0.03% of Vicus Capital's portfolio in Q1 2026, its #181 holding.
  • Vicus Capital first reported a position in Eli Lilly in Q1 2022 and has held it in 16 quarters since.
  • Vicus Capital's Eli Lilly position peaked at $747K in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.